1-deoxynojirimycin has been researched along with Ganglioside Storage Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jarnes Utz, JR; Kim, S; King, K; Redtree, ES; Schema, L; Whitley, CB; Ziegler, R | 1 |
Boomkamp, SD; Butters, TD; Dwek, RA; Fleet, GW; Neville, DC; Rountree, JS | 1 |
Butters, TD; d'Azzo, A; Dwek, RA; Elliot-Smith, E; Jeyakumar, M; Perry, VH; Platt, FM; Smith, DA; Thomas, R; van der Spoel, AC | 1 |
1 trial(s) available for 1-deoxynojirimycin and Ganglioside Storage Diseases
Article | Year |
---|---|
Infantile gangliosidoses: Mapping a timeline of clinical changes.
Topics: 1-Deoxynojirimycin; Diet, Ketogenic; Disaccharidases; Female; Gangliosidoses; Gangliosidoses, GM2; Gangliosidosis, GM1; Glycoside Hydrolase Inhibitors; Humans; Infant; Male; Prospective Studies; Retrospective Studies | 2017 |
2 other study(ies) available for 1-deoxynojirimycin and Ganglioside Storage Diseases
Article | Year |
---|---|
Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
Topics: 1-Deoxynojirimycin; Animals; Apoptosis; beta-N-Acetylhexosaminidases; Cell Line; Chromatography, High Pressure Liquid; Enzyme Activation; Gangliosidoses; Glycosphingolipids; Imino Sugars; Kinetics; Lysosomes; Mass Spectrometry; Mice; Oligosaccharides | 2010 |
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
Topics: 1-Deoxynojirimycin; Animals; Antigens, CD; Apoptosis; Biomarkers; Blood-Brain Barrier; Cytokines; Enzyme Inhibitors; Gangliosidoses; Gangliosidoses, GM2; Gangliosidosis, GM1; Genes, MHC Class II; Immunohistochemistry; Inflammation; Mice; Sandhoff Disease; Tay-Sachs Disease | 2003 |